dactinomycin has been researched along with salvicine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Miao, ZH; Qing, C; Tong, LJ; Zhang, JS | 1 |
1 other study(ies) available for dactinomycin and salvicine
| Article | Year |
|---|---|
Actinomycin D inhibiting K562 cell apoptosis elicited by salvicine but not decreasing its cytotoxicity.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Dactinomycin; Dose-Response Relationship, Drug; Drug Interactions; Drug Screening Assays, Antitumor; Humans; K562 Cells; Naphthoquinones | 2003 |